Microfluidics for mobile health
We are working with experienced partners to develop diagnostics for which it is desirable to employ very small volumes of samples to detect multiple analytes in parallel and in a minimum amount of time.
Our approach employs a library of microfluidic elements and benefits from pioneering contributions we have made with capillary-driven microfluidics and ultra-miniaturized immunoassays. We typically integrate reagents and receptors for analytes in microfluidic chips for performing immunoassays. The microfluidic chips are connected to a smartphone via a small chip peripheral, and our roadmap includes adding security and “intelligence” to these very precise microfluidic chips.
Originally supported by the Swiss Commission for Technology and Innovation (CTI) in partnership with the University Hospital of Basel, this research has now branched out into various directions. One of them was a FP7 EU project addressing respiratory tract infections and other projects involving various diagnostic and semiconductor companies. In addition, this research is part of the new IBM Research Frontiers Institute.